EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virtual insulin pump initiation is safe effective in children adolescents with type 1 diabetes

Benjamin Udoka Nwosu, Margaret Pellizzari, Maia N Pavlovic, Jason Ciron, Rashida Talib, Rubab Sohail

Frontiers in Clinical Diabetes and Healthcare · 30.04.2024 · 5

DOI: 10.3389/fcdhc.2024.1362627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 30.04.2024. Verfasst von Benjamin Udoka Nwosu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, Cohen Children's Medical Center, Hempstead, NY, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is no head-to-head comparison of the safety and efficacy of virtual versus in-office insulin pump initiation for youth with type 1 diabetes in the US. The study’s aim was to determine the safety and efficacy of virtual versus in-office pump initiation in pediatric type 1 diabetes. Research design and methods A longitudinal retrospective study of 112 subjects: 65% (n=73), ages 11.2 ± 3.8 years(y), received in-office training; and 35% (n=39), ages 12.0 ± 4.0y, received virtual training. The number of White subjects was 40 (55%) in the in-office group, and 25 (66%) in the remote group; while Black subjects were 11 (15%) in the in-office group and 4 (10%) in the virtual group. Data were collected at pump initiation, 3 and 6 months.

Results

There were no significant differences in sex, race, height, weight, BMI, and the duration of diabetes between the groups at baseline. There was no significant difference in A1c between the groups at 0, 3, and 6 months. A1c correlated significantly with the glucose management indicator at 0, 3, and 6 months: baseline: r=0.49, p<0.0001; 3 months: r=0.77, p<0.0001; and 6 months: r=0.71, p<0.0001. There was no relationship between A1c or TIR and pubertal status, BMI, sex, or race. A1c was significantly elevated in the non-White individuals at 6 months only: 57.9 mmol/mol (50.8-69.4) versus 51.9 mmol/mol (46.5-59.6)], p=0.007.

Conclusion

Virtual insulin pump initiation is safe and effective in children with type 1 diabetes. This approach could accelerate the adoption of the use of diabetes technology in minority populations in the US.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 pandemicadolescentschildrencontinuous glucose monitoringhemoglobin A1cinsulin pumptype 1 diabetes

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Pediatrics, Cohen Children's Medical Center, Hempstead, NY, United States.
  • Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Queens, NY, United States.
  • Biostatistics Unit, Office of Academic Affairs, Northwell Health, NY, United States.

Zitieren

APA

Nwosu, B. U., Pellizzari, M., Pavlovic, M. N., Ciron, J., Talib, R., & Sohail, R. (2024). Virtual insulin pump initiation is safe effective in children adolescents with type 1 diabetes. Frontiers in Clinical Diabetes and Healthcare, 5. https://doi.org/10.3389/fcdhc.2024.1362627

Vancouver

Nwosu BU, Pellizzari M, Pavlovic MN, Ciron J, Talib R, Sohail R. Virtual insulin pump initiation is safe effective in children adolescents with type 1 diabetes. Frontiers in Clinical Diabetes and Healthcare. 2024;5. doi:10.3389/fcdhc.2024.1362627

BibTeX
@article{Nwosu2024,
  author = {Nwosu, Benjamin Udoka and Pellizzari, Margaret and Pavlovic, Maia N and Ciron, Jason and Talib, Rashida and Sohail, Rubab},
  title = {Virtual insulin pump initiation is safe effective in children adolescents with type 1 diabetes},
  journal = {Frontiers in Clinical Diabetes and Healthcare},
  year = {2024},
  volume = {5},
  doi = {10.3389/fcdhc.2024.1362627}
}
Kostenlos starten →